Efficacy and safety of immune checkpoint inhibitors combined with anti-angiogenic agents compared to sorafenib or lenvatinib in the treatment of unresectable or advanced hepatocellular carcinoma a pairwise meta-analysis of randomized controlled trials.

Zijing Liu, Yu Jiang, Yaotiao Deng, Jie Liu